Stock Price
0.42
Daily Change
0.05 13.51%
Monthly
20.00%
Yearly
320.00%
Q1 Forecast
0.37

Starpharma Holdings reported AUD1.56M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Medical Developments International AUD 7.03M 5.91M Jun/2025
Mesoblast USD 18.85M 7.99M Jun/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025